Stem Cells Translational Medicine (SCTM) is dedicated to significantly advancing the clinical utilization of stem cell molecular and cellular biology. By bridging stem cell research and clinical trials, SCTM will help move applications of these critical investigations closer to accepted best practices.
Neural stem cells have strong potential to be effective in reducing brain injury in newborn babies, in the most extensive review of research on the topic.
Nov 25, 2021
0
29
Scientists are reporting promising results in the early stages of a clinical trial designed to gage the feasibility of a new type of treatment for people with acute kidney disease. Released in STEM CELLS Translational Medicine, ...
Sep 28, 2021
0
13
Are prematurely aged or overworked stem cells a significant factor in chronic lung disease? Findings of a study just released in STEM CELLS Translational Medicine say this is likely so.
Sep 21, 2021
0
3
A study released in STEM CELLS Translational Medicine (SCTM), by researchers at the Baker Institute for Animal Health, part of Cornell University's College of Veterinary Medicine, Ithaca, N.Y., details in a relevant ex vivo ...
Sep 16, 2021
0
9
A new phase I clinical study shows, for the first time, how treatment with a type of stem cell called mesenchymal stromal cells is able to regulate important factors driving inflammation in patients with chronic obstructive ...
Aug 18, 2021
0
7
Tendon injuries in sheep that were treated with stem cell grafts achieved, in just two months, a diameter and hardness similar to the original healthy tendon, according to the results of a study released in Stem Cells Translational ...
Aug 16, 2021
0
121
A study released in Stem Cells Translational Medicine has confirmed the safety of a novel type of cellular therapy for knee pain caused by osteoarthritis. Conducted by a multi-institutional team of researchers in Japan who ...
Aug 3, 2021
0
137
Results of a compassionate-use study released in Stem Cells Translational Medicine show promising results for treating muscular dystrophies with mesenchymal stem cells (MSCs) derived from Wharton's jelly (WJ), a substance ...
Jul 27, 2021
0
3
Answering a charge from the National Science Board, the RegenMed Development Organization (ReMDO), through its RegeneratOR Workforce Development Initiative, has released the results of a national survey of regenerative medicine ...
Jul 16, 2021
0
1
Critically ill COVID-19 patients treated with non-altered stem cells from umbilical cord connective tissue were more than twice as likely to survive as those who did not have the treatment, according to a study published ...
Jun 8, 2021
0
0
